J.P. Morgan is out with its report today on Cabot CBT, raising its PT from $44 to $50.
In a note to clients, J.P. Morgan writes, "We raised our December 2011 price target for Cabot from $44.00 to $50.00, which is consistent with the current share price reflecting our earnings adjustments and generally higher equity valuations for cyclical stocks in the market. Our price target is based on a 6.9x EV/EBITDA multiple for 2011E, which is in the range of a comparable peer group average of 5.3-10.0x EV/EBITDA for 2011E."
J.P. Morgan maintains Neutral on CBT.
Shares of CBT closed Thursday at $46.07, down 2.83% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in